HealthyDirect · GrowthFit for a long SIP
DSP Banking & Financial Services Fund
DSP Mutual FundEquity Schemes - Sectoral Fund2.9 years
The scheme seeks to seek to generate returns through investment in domestic and overseas equity and equity related securities of companies engaged in banking and financial services sector. There is no assurance that the investment objective of the Scheme will be achieved.
- NAV
- 14.183
- 30 Oct 2026
- 1Y
- -0.5%
- Trailing CAGR
- AUM
- ₹2,034.26 Cr
- 30 Sept 2026
- Volatility
- High
- 16.8% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 93% of rolling 1-year windows.
Fits if · Peak-to-trough drawdown has stayed shallower than 15%.
Buy checklist
History depth
Fail
2.9 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.80% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -14.7%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Vinit Sambre · 0.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 53.4% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 15%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y-0.5%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+12.7%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y-5.2%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +12.7%
- Calendar-day CAGR
- Excess 1Y
- +0.9%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -14.7%
- Worst peak-to-trough
- Current
- -11.2%
- Below last peak
- Current spell
- 60 days
- Days below latest peak
- Time below peak
- +88%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 10 days
- 43 recovered episodes
- Longest recovery
- 85 days
- Trough to prior peak
26 Feb 2026 – 24 Jun 2026
Trough 31 Mar 2026 · recovered in 85 days
-14.7%
31 Aug 2026 – open
Trough 26 Oct 2026 · not recovered
-12.1%
23 Sept 2024 – 17 Apr 2025
Trough 27 Jan 2025 · recovered in 80 days
-11.4%
3 Jun 2024 – 18 Jun 2024
Trough 4 Jun 2024 · recovered in 14 days
-8.1%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
21
Vs category
56
Consistency
93
Risk-adjusted
48
Drawdown
63
Mean
56
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 93% of rolling 1-year windows.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 34 holdings · top 10 are 53.4%.
- Top 5
- 31.3%
- Top 10
- 53.4%
- Largest holding
- 9.7%
- Effective holdings
- 22.6
ICICI Bank Ltd
Financial
9.7%
HDFC Bank Ltd
Financial
6.1%
Axis Bank Ltd
Financial
5.7%
Cholamandalam Investment & Finance Company Ltd
Financial
5.2%
State Bank of India
Financial
4.6%
What changed
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
DSP Healthcare Fund
DSP Mutual Fund
- 1Y
- +15.0%
- 3Y
- +21.6%
- Vol
- 14.3%
- Max DD
- -21.7%
- Sharpe
- 1.12
- 3Y win
- +60%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
BANDHAN FINANCIAL SERVICES FUND
Bandhan Mutual Fund
- 1Y
- -6.8%
- 3Y
- +12.6%
- Vol
- 15.4%
- Max DD
- -17.3%
- Sharpe
- 0.45
- 3Y win
- 0%
- Lower volatility
- Higher trailing returns
Caveat: Deeper drawdown · Higher TER
BANDHAN TRANSPORTATION AND LOGISTICS FUND
Bandhan Mutual Fund
- 1Y
- -1.8%
- 3Y
- +17.2%
- Vol
- 14.7%
- Max DD
- -25.0%
- Sharpe
- 0.86
- 3Y win
- +85%
- Lower volatility
- Higher trailing returns
Caveat: Deeper drawdown · Higher TER
Nippon India Pharma Fund
Nippon India Mutual Fund
- 1Y
- +9.1%
- 3Y
- +18.6%
- Vol
- 15.5%
- Max DD
- -24.0%
- Sharpe
- 0.75
- 3Y win
- +41%
- Lower volatility
- Higher trailing returns
Caveat: Deeper drawdown · Higher TER
WhiteOak Capital Pharma and Healthcare Fund
WhiteOak Capital Mutual Fund
- 1Y
- +19.5%
- 3Y
- n/a
- Vol
- 14.5%
- Max DD
- -15.4%
- Sharpe
- 1.08
- 3Y win
- n/a
- Lower volatility
- Higher trailing returns
Caveat: Deeper drawdown · Higher TER